NL-OMON22982招募中不适用
ong-term Patient Related OuTcomEs in lung Cancer Treatment (PROTECT): Influence of patient decisions on QOL, functionality and survival.
Medical Center LeeuwardenHenri Dunantweg 28934 AD Leeuwarden0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
one
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Newly diagnosed stage III or IV lung cancer, both histopathological proven as clinical diagnosis in patients not able to undergo invasive diagnostics.
排除标准
- •First line of cancer treatment for stage III or IV started in another hospital.
研究者
相似试验
招募中
不适用
ong-term Patient Related OuTcomEs in lung Cancer Treatment (PROTECT): Influence of patient decisions on QOL, functionality and survival.lung cancerNL-OMON46656Medisch Centrum Leeuwarden500
尚未招募
不适用
Defining the lung cancer patient population admitted to intensive care in Australiaung cancerCritical illnessRespiratory - Other respiratory disorders / diseasesCancer - Lung - Non small cellCancer - Lung - Small cellCancer - Lung - MesotheliomaLung cancerACTRN12620000508976Sunshine Coast University Hospital60
已完成
不适用
Neoadjuvant Immunochemotherapy for Lung CancerLung CancerNCT06023797Shanghai Zhongshan Hospital83
Unknown
不适用
The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine KinaseNon-Small-Cell Lung CancerNCT02755337Dr. Soetomo General Hospital70
招募中
不适用
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung CancersLung AdenocarcinomaNon Small Cell Lung CancerSmall-cell Lung CancerLung CancerLung Squamous Cell CarcinomaNCT06255197Cancer Institute and Hospital, Chinese Academy of Medical Sciences60,000